Spacelabs Healthcare recently introduced its newest clinical application suite, the ICS G2, which is designed to improve efficiency and information flow by applying clinical logic to the presentation of the data
June 2, 2008 - U.S. News & World Report published the 2008 edition of America’s Best Children’s Hospitals, published ...
June 2, 2008 - Abbott has submitted an application for Seizo Hanbai Shonin (Marketing Authorization License) to Japan's ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Spectrum Surgical Instruments Corp. introduced a new kit for testing surgical instruments for proper sharpness. The ...
June 2, 2008 - Spectrum Surgical Instruments Corp. this week introduced a new kit for testing surgical instruments for ...
June 2, 2008 - Computed tomography angiography (CTA) offers a way to more quickly and cost effectively identify patients ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 2, 2008 - Abiomed Inc. received 510(k) clearance from FDA for Impella 2.5 Device Cardiac Assist Device, allowing ...
June 2, 2008 - Agfa HealthCare will exhibit its IMPAX Cardiovascular suite, a structured results management solution ...
Braemar Inc. rolled out the DL900, a 1.75 ounce, compact digital Holter monitor with a large liquid crystal display (LCD) and extended recording time of up to seven days. The new model includes a newly designed, custom analog IC for signal acquisition is the technology platform for the advanced capabilities of the DL900.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
June 2, 2008 - Beta-blocker usage for elective abdominal aortic aneurysm (AAA) repair reduced in-hospital mortality by 51 percent compared to control hospitals over the same time period, according to findings published in the 2008 issue of the Journal of Vascular Surgery.
June 2, 2008 – Spacelabs Healthcare recently introduced its newest clinical application suite, the ICS G2, which is ...
The vProtect Luminal Shield is a self-expanding intracoronary prosthesis designed to limit arterial injury that typically occurs when stents are deployed. The Shield reportedly also provides robust biocompatible support for the vessel to ensure that the target coronary artery will remain patent after placement.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 30, 2008 - Three patients with established cardiac ischemia recently became the first recipients of the vProtect Luminal Shield, a self-expanding intracoronary prosthesis designed to limit arterial injury that typically occurs when stents are deployed.
May 30, 2008 - Adroit Medical Systems Inc. this week was award a 36-month supplier agreement by Premier Purchasing ...
May 29, 2008 – Providing objective metrics and educational feedback to medical personnel who performed CPR on a cardiac arrest patient significantly improved ventilation rate, compression rate and depth of compression, and was associated with higher initial survival rates for cardiac arrest patients, according to results published in the Archives of Internal Medicine from the Resuscitation with
June 01, 2008
